Rodolfo Alejandro

This study follows up to 30 people with type 1 diabetes who previously received islet cell transplants. Researchers want to see how long the transplanted cells keep working to control blood sugar. Participants must continue taking immunosuppressive drugs to prevent rejection.

This study tests whether the drug Myfortic can prevent the immune system from becoming sensitized after a failed islet transplant in people with type 1 diabetes. Participants have already lost their graft and will take Myfortic alone for two years. The goal is to see if this redu…

This study follows people with type 1 diabetes who have had an islet transplant that later stopped working. Researchers want to learn how the body's immune system changes after the graft is lost. The goal is to gather information, not to test a new treatment.